#1 Clinical Trials Search in Europe

Lactose

Lactose, a sugar commonly found in dairy products, plays a significant role in clinical trials as both a placebo and an excipient. This article explores various studies where lactose has been used to investigate the effectiveness of different medications and treatments across a range of medical conditions. We’ll examine how lactose is utilized in these trials and its importance in the development of new therapies.

Table of Contents

What is Lactose?

Lactose is a sugar naturally found in milk and dairy products. In medical research, it is often used as a placebo, which is an inactive substance given to some participants in clinical trials[1]. A placebo looks like the real treatment but has no active ingredients. This helps researchers compare the effects of the actual drug being studied to no treatment at all.

Uses in Clinical Trials

In the clinical trials reviewed, lactose was used as a placebo in various ways:

  • As a powder to be dissolved in water and taken orally[2]
  • In capsule form to be swallowed[3]
  • As a coated tablet[4]

The purpose of using lactose as a placebo is to create a control group in the study. This allows researchers to compare the effects of the actual drug being tested to an inactive substance, helping them determine if the drug is truly effective.

Conditions Studied

Lactose as a placebo has been used in clinical trials studying various conditions, including:

  • High Altitude Headache: A type of headache that occurs when people ascend to high altitudes[1]
  • Chemotherapy-Induced Nausea and Vomiting: Side effects experienced by cancer patients undergoing chemotherapy[2]
  • Urinary Tract Infections (UTIs): Infections affecting the urinary system[5]
  • Calcific Tendonitis: A condition where calcium deposits form in the tendons, causing pain[3]
  • Nocturnal Enuresis: Also known as bedwetting[6]
  • Traveler’s Diarrhea: Digestive issues that can occur when traveling to different countries[4]
  • Pain after Cesarean Delivery: Post-surgical pain experienced by women who have undergone a C-section[7]
  • Migraine: A type of severe headache often accompanied by other symptoms like nausea and sensitivity to light[8]

How is Lactose Administered?

The administration of lactose as a placebo varies depending on the study design and the drug it’s being compared to. Some common methods include:

  • Oral powder: 2.7 grams dissolved in water, taken every 8 hours[2]
  • Capsules: Taken once or twice daily[3]
  • Tablets: Taken as directed in the study protocol[4]

The dosage and frequency of administration are designed to match the active drug being studied, so participants don’t know whether they’re receiving the actual treatment or the placebo.

Safety and Side Effects

Lactose is generally considered safe for most people when used as a placebo. However, it’s important to note that some individuals may be lactose intolerant, meaning their bodies have difficulty digesting lactose. For these people, consuming lactose can cause symptoms such as:

  • Bloating
  • Gas
  • Abdominal cramps
  • Diarrhea

If you’re participating in a clinical trial and experience any unusual symptoms, it’s crucial to report them to the study coordinators, even if you think you might be in the placebo group.

Important Considerations for Patients

If you’re considering participating in a clinical trial, here are some important points to keep in mind:

  • Inform the researchers if you have any known allergies or intolerances, including lactose intolerance.
  • Understand that you may receive a placebo instead of the active treatment being studied.
  • Follow the study protocol carefully, including taking the medication (or placebo) as directed.
  • Report any side effects or changes in your condition to the study coordinators promptly.
  • Remember that participating in a clinical trial contributes to medical research and may help develop new treatments for various conditions.

By serving as a placebo in clinical trials, lactose plays a crucial role in advancing medical research and helping to develop new treatments for a wide range of conditions. While it doesn’t directly treat any diseases, its use in research is invaluable for determining the effectiveness of new medications and therapies.

Condition Drug Tested Lactose Use Study Design Key Findings
Asthma Prednisone, Colecalciferol Placebo (0.3mg) Double-blind, placebo-controlled Investigated effects on regulatory T cells and cytokines
Chemotherapy-Induced Nausea and Vomiting Persumac (Iranian traditional remedy) Placebo (2.7g) Double-blind, placebo-controlled, cross-over Assessed effect on frequency and severity of nausea/vomiting
Urinary Tract Infections D-Mannose Placebo (2g) Double-blind, placebo-controlled Evaluated prevention of recurrent UTIs
Calcific Tendonitis Colchicine Placebo capsules Double-blind, placebo-controlled Assessed efficacy for chronic shoulder pain
Nocturnal Enuresis Melatonin Placebo capsules Double-blind, randomized, cross-over Investigated effect on bedwetting episodes
Travellers’ Diarrhoea Rifaximin Placebo (coated tablet) Double-blind, placebo-controlled Evaluated prophylactic treatment efficacy
Influenza DAS181 Placebo (not specified) Double-blind, randomized, placebo-controlled Assessed safety and tolerability of DAS181
Post-Cesarean Pain Gabapentin Placebo capsules Double-blind, randomized, placebo-controlled Evaluated pain reduction and maternal satisfaction
Migraine BGC20-1531 Placebo (oral administration) Double-blind, placebo-controlled, cross-over Assessed efficacy in reducing migraine pain

FAQ

  • What is the primary use of lactose in clinical trials? Lactose is primarily used as a placebo or inactive ingredient in clinical trials. It serves as a control substance to compare the effects of active medications against an inert substance.
  • Is lactose safe for use in clinical trials? Generally, lactose is considered safe for use in clinical trials. However, individuals with lactose intolerance may experience mild digestive discomfort. Researchers typically screen participants for lactose intolerance before including them in studies using lactose as a placebo.
  • How is lactose administered in clinical trials? Lactose can be administered in various forms depending on the study design. It may be given as a powder to be dissolved in water, in capsules, or as coated tablets. The method of administration is usually matched to that of the active drug being studied.
  • Why is lactose chosen as a placebo in many clinical trials? Lactose is often chosen as a placebo because it is inert, widely available, and easily formulated into various dosage forms. It also has a neutral taste and appearance, making it difficult for participants to distinguish from active medications.
  • Can lactose affect the results of a clinical trial? While lactose is generally considered inert, it's important to note that some individuals may experience a placebo effect. This is why double-blind, placebo-controlled studies are crucial in determining the true efficacy of a medication compared to a lactose placebo.

Ongoing Clinical Trials on Lactose

  • Study on Chiropractic Therapy and Ibuprofen for Acute Neck Pain in Adults

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Placebo: An inactive substance or treatment that looks identical to the active drug or treatment being tested in a clinical trial. It is used as a control to measure the effectiveness of the active treatment.
  • Excipient: An inactive substance used as a vehicle or medium for a drug or other active substance. In the context of these trials, lactose often serves as an excipient in placebo formulations.
  • Double-blind: A study design where neither the participants nor the researchers know who is receiving the active treatment and who is receiving the placebo until after the trial is completed.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly assigned to different treatment groups, including a control group, to compare the effects of different interventions.
  • Crossover study: A type of clinical trial where participants receive a sequence of different treatments, including both the active drug and placebo, with periods of no treatment (washout) in between.
  • Washout period: A period of time during a clinical trial when participants stop taking any study medications to allow the effects of the drug to wear off before starting the next phase of the study.
  • Efficacy: The ability of a drug or treatment to produce the desired effect under ideal circumstances, such as in a controlled clinical trial.
  • Adverse effects: Unwanted or harmful reactions that occur as a result of taking a medication or undergoing a treatment.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Visual Analog Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, often used in pain assessment.

References

  1. https://clinicaltrials.gov/study/NCT01288781
  2. https://clinicaltrials.gov/study/NCT02787707
  3. https://clinicaltrials.gov/study/NCT00983177
  4. https://clinicaltrials.gov/study/NCT00979056
  5. https://clinicaltrials.gov/study/NCT03497598
  6. https://clinicaltrials.gov/study/NCT01575678
  7. https://clinicaltrials.gov/study/NCT01848119
  8. https://clinicaltrials.gov/study/NCT00888680